At a glance
The ÐÇ¿ÕÓéÀÖ¹ÙÍø Division of Viral Hepatitis provides leadership in science and public health practices to prevent and control viral hepatitis.
What's included
ÐÇ¿ÕÓéÀÖ¹ÙÍø works collaboratively with funded programs and partners to meet the goals of the Division of Viral Hepatitis' 2025 Strategic Plan. This includes:
- Advancing viral hepatitis research.
- Developing and promoting viral hepatitis national testing and vaccination recommendations.
- Supporting jurisdictions to conduct surveillance and increase access to prevention, diagnosis, and linkage to care services.
- Monitoring viral hepatitis disease trends.
- Detecting and responding to outbreaks.
- Increasing public awareness of viral hepatitis.
- Working with partners to increase access to prevention, diagnosis, and treatment services for all populations, including disproportionately affected populations (for example, people with substance use disorder, justice-involved populations, and people living with human immunodeficiency virus [HIV]).
ÐÇ¿ÕÓéÀÖ¹ÙÍø-funded programs and partners
The IVHSP program supports integrated viral hepatitis surveillance and prevention programs in states, territories, and large cities in the United States over 5 years (2021–2026). To read more about program goals and funded jurisdictions, see:
This cooperative agreement funds organizations that provide culturally responsive hepatitis B and/or hepatitis C education and services to priority populations to increase awareness, testing, and treatment. The agreement also supports organizations that provide free web-based training for clinicians to increase their knowledge and skills around preventing, testing, and treating hepatitis B and hepatitis C.
This cooperative agreement increases access to harm reduction services for people who inject drugs and aims to prevent viral hepatitis, HIV, and other infectious diseases associated with injection drug use.